Actinium Pharmaceuticals
ATNM
$8.86
Share price
-8.57%
Change (1 day)
-1.01%
Change (1 year)
Categories
Actinium Pharmaceuticals (ATNM) - Total debt
Total debt on the balance sheet as of March 2024 : $1.98 M
According to Actinium Pharmaceuticals's latest financial reports the company's total debt is $1.98 M. A company’s total debt is the sum of all current and non-current debts.
Actinium Pharmaceuticals - Total debt on balance sheet (from 2006 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $2.58 M | 732.58% |
| 2021-12-31 | $0.31 M | -57.99% |
| 2020-12-31 | $0.73 M | -48.32% |
| 2019-12-31 | $1.42 M | 443.81% |
| 2018-12-31 | $0.26 M | |
| 2017-12-31 | $N/A | |
| 2016-12-31 | $N/A | -100% |
| 2015-12-31 | $0.26 M | -6.3% |
| 2014-12-31 | $0.28 M | 79.66% |
| 2013-12-31 | $0.15 M | 12.73% |
| 2012-12-31 | $0.14 M | 12.57% |
| 2011-12-31 | $0.12 M | |
| 2009-12-31 | $0.06 M | 37.5% |
| 2008-12-31 | $0.04 M | 38.57% |
| 2007-12-31 | $0.03 M | 147.99% |
| 2006-12-31 | $0.01 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Genocea Biosciences
GNCA | $15.48 M | 681.28% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $0.44 B | 22,355.05% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.09 B | 55,224.92% | 🇺🇸 USA |